Safety and feasibility of outpatient hematopoietic cell transplantation in pediatric patients during the COVID-19 pandemic: A single-center experience

Pediatr Blood Cancer. 2021 Dec;68(12):e29252. doi: 10.1002/pbc.29252. Epub 2021 Jul 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Child
  • Feasibility Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Outpatients
  • Pandemics
  • SARS-CoV-2